T2D is a chronic syndrome that is caused due to dysregulation of blood sugar levels. The research collaboration is expected to address underlying pathologies of diabetes, which is
Under the Javelin Ovarian 200 open-label, parallel group, global study, the companies will assess the superiority of avelumab as monotherapy or in combination with pegylated liposomal doxorubicin (PLD)
The company is investing KRW850bn ($723m) in the new plant, which will boast a production capacity of 180,000 liters to become the single largest biologics manufacturing facility in
Medidata’s technology platform will allow the pharmaceutical firm to carry out faster and more accurate clinical trials. The study planning, data management, data analytics and risk-based monitoring (RBM)
The JV will unite CRISPR Therapeutics’ CRISPR-Cas9 gene editing technology with Bayer’s protein engineering and disease expertise. Bayer will invest a minimum of $300m in the JV over
Under the deal, Janssen will acquire exclusive rights to Bavarian’s MVA-BN technology for use in a prime-boost vaccine regimen together with its AdVac technology to target all cancers
The committee recommended approval for the company’s lesinurad 200 mg tablets, in combination with a xanthine oxidase inhibitor (XOI), for the adjunctive treatment of of hyperuricaemia in adults
GSK’s global HIV business, ViiV Healthcare, has signed two separate transactions, which are expected to complete independently during the first half of next year. The deals are subject
Shkreli is alleged of misappropriating money from two hedge funds he established and made material misrepresentations to investors among other widespread misconduct. Shkreli earlier faced criticism for drastically
Acerta Pharma has operations in Oss, the Netherlands and several US sites. The US headquarters is in Redwood City, California. The deal gives AstraZeneca access to Acerta’s lead
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.